NASDAQ:QDEL QuidelOrtho Q3 2026 Earnings Date & Estimates $13.42 +1.01 (+8.14%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$13.30 -0.12 (-0.86%) As of 10/9/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. QuidelOrtho is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for 5:00 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 4, 2026TimeAfter Market ClosesConference Call5:00 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from QuidelOrtho in Q3 2026QuidelOrtho is expected to post earnings of $0.2023 per share on revenue of $628.08 million. In the same quarter a year earlier QuidelOrtho reported $0.80 per share on revenue of $699.90 million. QuidelOrtho last reported on August 6, 2026, posting $0.13 per share and beating the -$0.0488 consensus estimate. QuidelOrtho has beaten the consensus EPS estimate in 6 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.2023Expected Revenue$628.08 millionPrior-Year EPS$0.80Prior-Year Revenue$699.90 millionExpected EPS Growth-74.7%Expected Revenue Growth-10.3%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.13 (Beat by +$0.1788)Last Quarter Revenue$630.90 millionEPS Beat Rate6 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report QuidelOrtho Q3 2026 Earnings FAQ When does QuidelOrtho report Q3 2026 earnings? QuidelOrtho (NASDAQ:QDEL) is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. What time is QuidelOrtho's Q3 2026 earnings call? QuidelOrtho's Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for QuidelOrtho? Analysts expect QuidelOrtho to post earnings of $0.2023 per share for Q3 2026. How much revenue is QuidelOrtho expected to report? The consensus revenue estimate for QuidelOrtho is $628.08 million for Q3 2026. QuidelOrtho Earnings HeadlinesDid QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?October 8 at 2:50 PM | prnewswire.comQuidelOrtho: Margins Recover, Cash Does NotOctober 7 at 12:18 PM | seekingalpha.comTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.October 10 at 1:00 AM | Banyan Hill Publishing (Ad)QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor RelationsOctober 7 at 7:13 AM | prnewswire.comQuidelOrtho rallies 13% to multi-week highOctober 5, 2026 | seekingalpha.comQuidelOrtho (NASDAQ:QDEL) Shares Climb 7.2% - Time to Buy?October 5, 2026 | americanbankingnews.comSee More QuidelOrtho Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like QuidelOrtho? Sign up for Earnings360's daily newsletter to receive timely earnings updates on QuidelOrtho and other key companies, straight to your email. Email Address About QuidelOrthoQuidelOrtho (NASDAQ:QDEL) (NASDAQ:QDEL) develops, manufactures and distributes diagnostic products used by healthcare providers, clinical laboratories and blood-processing organizations. The company’s offerings are designed to support the detection, diagnosis and monitoring of infectious diseases, cardiovascular conditions and other medical conditions. Its product portfolio includes point-of-care testing systems, molecular diagnostic assays, immunoassays, clinical chemistry and immunodiagnostic platforms, as well as transfusion medicine products. Key product families include the Sofia and Savanna point-of-care systems, VITROS laboratory analyzers and assays, and ORTHO BioVue blood-typing and screening technologies. QuidelOrtho was created through the combination of Quidel Corporation and Ortho Clinical Diagnostics, which was completed in 2022. The company is headquartered in San Diego, California, and serves healthcare institutions, reference laboratories, physician offices, pharmacies, blood centers and other customers in the United States and international markets.View QuidelOrtho ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
